Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fournel1, S"'
Autor:
Jacoberger-Foissac, C., Heurtault, B., Fournel, S., Frisch, B., Flacher, V., Heurtault1, B, Fournel1, S
Publikováno v:
European Journal of Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer, 2019, Vienna, Austria. pp.S15, ⟨10.1016/j.ejca.2019.01.056⟩
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer, 2019, Vienna, Austria. pp.S15, ⟨10.1016/j.ejca.2019.01.056⟩
International audience; Background: Despite being quite effective, conventional cancer therapies have the major drawback of triggering numerous side effects. Currently, a challenging goal in this area is the development of innovative targeted antitum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ca043f29462ce2c5accb86ab0fb303
https://hal.archives-ouvertes.fr/hal-02347530
https://hal.archives-ouvertes.fr/hal-02347530
Autor:
Wantz, M., Chekkat, N., Bouché, M., Dahm, G., Bellemin-Laponnaz, S., Fournel, S., Wantz1, M, Chekkat1, N, Bouche´, M, Dahm2, G, Kichler, A., Frisch, B., Bellemin-Laponnaz2, S, Fournel1, S
Publikováno v:
European Journal of Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer, 2019, Vienna, Austria. pp.S31-S32, ⟨10.1016/j.ejca.2019.01.094⟩
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer, 2019, Vienna, Austria. pp.S31-S32, ⟨10.1016/j.ejca.2019.01.094⟩
International audience; Background: Platinum (II)-based drugs are widely used chemother-apeutic agents. However, as they have many side effects, numerous platinum (Pt) derivatives have been developed during the last years. Furthermore, some cancer tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b6f713bec396c53fb6e7898f54add3
https://hal.archives-ouvertes.fr/hal-02347590/document
https://hal.archives-ouvertes.fr/hal-02347590/document